| Name | 2-fluoro-4-(1-methylimidazol-2-yl)aniline |
|---|
| Molecular Formula | C10H10FN3 |
|---|---|
| Molecular Weight | 191.20500 |
| Exact Mass | 191.08600 |
| PSA | 43.84000 |
| LogP | 2.38960 |
|
~83%
218301-90-7 |
| Literature: Bristol-Myers Squibb Pharma Company Patent: EP991638 B1, 2005 ; Location in patent: Page/Page column 54 ; |
|
~%
218301-90-7 |
| Literature: Quan, Mimi L.; Lam, Patrick Y. S.; Han, Qi; Pinto, Donald J. P.; He, Ming Y.; Li, Renhua; Ellis, Christopher D.; Clark, Charles G.; Teleha, Christopher A.; Sun, Jung-Hui; Alexander, Richard S.; Bai, Steve; Luettgen, Joseph M.; Knabb, Robert M.; Wong, Pancras C.; Wexler, Ruth R. Journal of Medicinal Chemistry, 2005 , vol. 48, # 6 p. 1729 - 1744 |
|
~%
218301-90-7 |
| Literature: Quan, Mimi L.; Lam, Patrick Y. S.; Han, Qi; Pinto, Donald J. P.; He, Ming Y.; Li, Renhua; Ellis, Christopher D.; Clark, Charles G.; Teleha, Christopher A.; Sun, Jung-Hui; Alexander, Richard S.; Bai, Steve; Luettgen, Joseph M.; Knabb, Robert M.; Wong, Pancras C.; Wexler, Ruth R. Journal of Medicinal Chemistry, 2005 , vol. 48, # 6 p. 1729 - 1744 |
| Precursor 2 | |
|---|---|
| DownStream 0 | |